Drug Shortage Report for GD-TRANEXAMIC ACID

Last updated on 2019-02-12 History
Report ID 68477
Drug Identification Number 02409097
Brand name GD-TRANEXAMIC ACID
Common or Proper name Tranexamic Acid
Company Name GENMED A DIVISION OF PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) TRANEXAMIC ACID
Strength(s) 500MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100's
ATC code B02AA
ATC description ANTIFIBRINOLYTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-12-18
Estimated end date
Actual end date 2019-02-11
Shortage status Resolved
Updated date 2019-02-12
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-800-387-4974 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-12-03 English Compare
v2 2018-12-03 French Compare
v3 2018-12-19 English Compare
v4 2018-12-19 English Compare
v5 2018-12-19 French Compare
v6 2019-01-07 English Compare
v7 2019-01-07 French Compare
v8 2019-01-31 English Compare
v9 2019-01-31 French Compare
v10 2019-02-08 English Compare
v11 2019-02-08 French Compare
v12 2019-02-11 English Compare
v13 2019-02-11 French Compare
v14 2019-02-12 English Compare

Showing 1 to 14 of 14